TAK-901
- Generic Name
- TAK-901
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H32N4O3S
- CAS Number
- 934541-31-8
- Unique Ingredient Identifier
- DM9UIR23R7
- Background
TAK-901 has been used in trials studying the treatment of Lymphoma, Myelofibrosis, Multiple Myeloma, Myeloid Metaplasia, and Advanced Solid Tumors, among others.
- Associated Conditions
- -
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath